Antihemophilic factor now OK for surgery
Patients with von Willebrand disease (vWD) undergoing surgery may now benefit from the use of Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) to prevent excessive bleeding during and after surgery.
Patients with von Willebrand disease (vWD) undergoing surgery may now benefit from the use of Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) to prevent excessive bleeding during and after surgery. The biologic was previously approved for use in adult patients to treat and prevent bleeding from hemophilia A and also for the treatment of spontaneous and traumatic bleeding in patients with vWD when desmopressin use is inadequate. The product contains the clotting proteins from human plasma that patients with vWD are lacking.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
